Alkim Alkali committed TRY 220.30 million. Alkim Alkali stock sits 47.68 percent below its high

Published on 10/14/2026 at 00:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alkim Alkali reported a TRY 142.90 million first-half loss. Alkim Alkali stock was valued at TRY 3.40 billion on October 13, 2026.

Capital funding and first half results

Alkim Alkali committed TRY 220.30 million on September 28, 2026.
First-half 2026 sales reached TRY 2.80 billion, while net income was a TRY 142.90 million loss.
Alkim Alkali stock had a TRY 3.40 billion market value on October 13, 2026.

Alkim Alkali, TRAALKIM91E0, Illustration mit AI erstellt.

Alkim Alkali committed TRY 220.30 million on September 28, 2026, to participate in the rights offering of subsidiary Alkim Kagit, according to Paranin Yonu. Alkim Alkali stock had a TRY 3.40 billion market value on October 13, 2026, while the last quoted price stood at TRY 11.28.

Chronology of capital decisions

The latest capital step followed a September 25, 2026 decision to raise Alkim Kagit's paid-in capital from TRY 735.00 million to TRY 1.01 billion through a TRY 275.63 million rights offering, as reported by Yeni Safak. On September 28, 2026, Alkim Alkali confirmed its participation with TRY 220.30 million, with payments to be made in installments under the reported decision.

The chronology also reaches back to June 1, 2026, when the company published first-half financial statements. The capital commitment therefore sits alongside a balance-sheet event and a recent operating update, rather than standing as an isolated corporate action.

What do the first-half figures show?

According to FVT, first-half 2026 net sales reached TRY 2.80 billion, while net income was a TRY 142.90 million loss. The same report listed TRY 78.40 million of earnings before interest, taxes, depreciation and amortization and TRY 4.90 billion of equity for the period.

For investors, the key comparison is between the TRY 2.80 billion sales base and the TRY 142.90 million loss. The planned TRY 220.30 million subsidiary investment is smaller than first-half sales but larger than the reported operating profit measure, making funding discipline a central issue in the capital story.

Turkey listing and valuation

Alkim Alkali is listed on Borsa Istanbul under ticker ALKIM and operates in basic materials, with chemical products and paper among its activities. The quoted 52-week range was TRY 11.15 to TRY 21.56 as of October 13, 2026, placing the TRY 11.28 price near the lower end of that range.

The latest available market view combines a TRY 3.40 billion market value with TRY 7.70 billion of total assets and TRY 4.90 billion of equity for the first half of 2026. That combination leaves the subsidiary funding decision and the company's ability to convert sales into profit as the clearest indicators for the next update.

Capital needs meet weak profitability

The last quoted Borsa Istanbul price was TRY 11.28 on October 13, 2026. Alkim Alkali stock remains tied to the outcome of the subsidiary capital increase, while the first-half loss gives the funding decision a measurable profitability backdrop.